Question Title

* 1. What are the symptoms most commonly associated with COPD?

Question Title

* 2. What are the risk factors for COPD?

Question Title

* 3. What environmental exposures increase risk of COPD?

Question Title

* 4. How can COPD, asthma, and congestive heart failure be differentiated clinically?

Question Title

* 5. What are key features of COPD etiology (e.g., onset, progression)?

Question Title

* 6. Who should be screened for COPD using spirometry, according to clinical guidelines established by organizations such as the American Thoracic Society/European Respiratory Society (ATS/ERS) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD)?

Question Title

* 7. What do the critical parameters of spirometry (e.g., FVC, FEV1, FEV1/FVC) measure?

Question Title

* 8. How is FEV1/FVC used to assess airway obstruction and thus aid clinical decision-making?

Question Title

* 9. What constitutes appropriate spirometry technique to ensure a viable reading?

Question Title

* 10. What codes are used to request reimbursement for spirometry?

Question Title

* 11. How can reversibility of airflow limitation be assessed using bronchodilators?

Question Title

* 12. What are the four basic patterns of spirometry results, and what do these look like graphically?

Question Title

* 13. How are spirometry results used to diagnose and stage COPD?

Question Title

* 14. What are some strategies to help individuals with COPD stop smoking?

Question Title

* 15. How do I develop a COPD action plan for a patient?

Question Title

* 16. What classes of agents are FDA-approved to manage stable COPD (e.g., bronchodilators [β2-agonists, anticholinergics, methylxanthines], inhaled glucocorticoids), and how do these agents work?

Question Title

* 17. When should pharmacotherapy be initiated?

Question Title

* 18. When should combination pharmacotherapy be considered?

Question Title

* 19. What are the recommendations for influenza and pneumococcal vaccines for individuals with COPD?

Question Title

* 20. Who should receive supplemental long-term oxygen therapy?

Question Title

* 21. What are the components of a pulmonary rehabilitation program?

Question Title

* 22. What are COPD exacerbations?

Question Title

* 23. How do pharmacologic treatment regimens differ for stable COPD and exacerbations (e.g., PDE-4 inhibitors, systemic glucocorticosteroids, antibiotics)?

Question Title

* 24. What are the indications for hospitalization for COPD exacerbations?

Question Title

* 25. When should a COPD patient be referred to a pulmonary specialist?

T